Start date: 2003-01-01, End date: 2006-12-31
Vaccine candidates are emerging but the time and cost of TB clinical trials prohibits their evaluation. Surrogate markers are needed. Cells from carefully followed up contacts who do or do not develop disease are being studied forcytokine expression by RT-PCR in 3 African cent...
Programme: FP5-INCO 2
Record Number: 67343
Last updated on: 2005-04-12